Financials
Financial year 2025
Clinical Trial Advising Bureau from Kampenhout, company number BE0533752891, closed financial year 2025 with a result of € -216 after tax. For that financial year Clinical Trial Advising Bureau recorded a gross margin of € 8,134 and equity of € 105,058. Compared with financial year 2024, the result moved from € 10,170 to € -216. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 105,058
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -216
▼ still € 10,170 profit in 2024
Profit after tax over the fiscal year.
€ 78,769
▼ 5% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 98,858.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 8,583
▼ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 268
▼ 91% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,487
▼ 1% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 15,837 | € 31,421 | € 20,381 | € 8,134 | ▼ 60% |
| Profit after taxes | € 6,975 | € 19,154 | € 10,170 | € -216 | ▼ € 10,386 |
| Equity | € 80,950 | € 100,104 | € 110,274 | € 105,058 | ▼ 5% |
| Total debts | € 26,217 | € 11,059 | € 10,691 | € 13,108 | ▲ 23% |
| Cash | € 84,468 | € 84,743 | € 82,541 | € 78,769 | ▼ 5% |
| Land & buildings | - | - | € 1,241 | € 3,786 | ▲ 205% |
| Retained profit | € 74,750 | € 93,904 | € 104,074 | € 98,858 | ▼ 5% |
| Dividend | € 0 | € 0 | € 0 | € 5,000 | |
| Balance sheet total | € 107,166 | € 111,163 | € 120,965 | € 118,166 | ▼ 2% |
Key figures of Clinical Trial Advising Bureau, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Clinical Trial Advising Bureau?
What happened at Clinical Trial Advising Bureau in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 216 (▼ € 10,386 vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Steenokkerzeel. KBO
In short
From € 6,975 profit in 2022 to € 216 loss in 2025.
Paid € 19,676 in corporate taxes since 2022.
Best year ever: 2023, with € 19,154 profit.
Paid out € 5,000 in dividends to the owners in total.
A new publication or filing at Clinical Trial Advising Bureau? We notify you, reason included.
Follow Clinical Trial Advising BureauDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Clinical Trial Advising Bureau is Ingrid Develter.
Directors
According to the 2025 annual accounts
Ingrid Develter
Director
Establishments
Establishment units
Physical locations of this company
Heystraat 5 box A
1910 Kampenhout
Dijkstraat 11
1820 Steenokkerzeel
Active since 18 April 2013
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0533.752.891
- VAT number
- BE 0533.752.891
- Registered office
- Heystraat 5 bus A, 1910 Kampenhout
- Names & denominations
- Clinical Trial Advising Bureau · CTAB
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 April 2013
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria